NCCN-protocol care · 96.9% 1-yr breast cancer survival · ArogyaSri, CGHS & cashless insurance accepted · Free second opinion
1800 202 8726
Understanding your ultrasound report

TI-RADS explained — thyroid ultrasound scoring

Medically reviewed by Dr. Owais Mohammed, Medical Oncologist, MBBS · MD  ·  Last reviewed June 2026

If your scan report mentions a TI-RADS score, it simply describes how suspicious a thyroid nodule looks on ultrasound — on a scale from TR1 to TR5. This page explains the tirads 3, 4 and 5 meaning in plain words, how the thyroid ultrasound score is worked out, and when a nodule actually needs a biopsy.

  • TR1 to TR5 — a simple scale from benign to highly suspicious
  • A score, not a diagnosis — only a biopsy can confirm cancer
  • Score + size decide the biopsy — not the score alone
  • Most nodules are benign — even most high-score ones
4.8 · 800+ Google reviews · 15,000+ patients treated
Limited Slots Today

Have a TI-RADS Report? Get It Reviewed Free

₹950   Today: FREE  ·  Including free written second opinion

Free 45-minute oncology consultation
No unnecessary tests, ever
Confidential. No commitment to start treatment.
or
Call 1800 202 8726
17+
Cancer Specialists
on Panel
96.9%
Breast Cancer
Survival Rate*
15,000+
Patients
Treated
4.8★
Google Rating
(800+ reviews)

What Is TI-RADS on a Thyroid Ultrasound?

TI-RADS stands for Thyroid Imaging Reporting and Data System. It is a standardised way for a radiologist to describe how suspicious a thyroid nodule looks on ultrasound, using a single score. The version most widely used in India was published by the American College of Radiology (ACR).

The idea is simple. A thyroid lump on its own tells you very little — most are completely harmless. TI-RADS looks at the specific features of the nodule on the scan and turns them into a number, so that two doctors looking at the same nodule describe its risk in the same way.

The result is a level from TR1 (benign) to TR5 (highly suspicious). The higher the level, the more closely the nodule needs to be looked at — but a high score is still only a flag for further checking, never a diagnosis on its own.

Did you know?

A thyroid nodule is extremely common — by some estimates, more than half of adults have at least one if scanned, yet only a small fraction are cancer. TI-RADS exists precisely so that benign nodules are not biopsied unnecessarily, and the few that matter are not missed. (Source: American College of Radiology — ACR TI-RADS White Paper.)

tirads 3 4 5 meaning

What Each TI-RADS Level Means — TR1 to TR5

Each level reflects how likely a nodule is to be cancerous, based on its appearance on the scan. These are broad, ACR-based risk estimates — your specialist reads them alongside the nodule's size and your own history.

  • TR1 — Benign: no nodule of concern was seen. A normal, reassuring result with essentially no cancer risk. No biopsy needed.
  • TR2 — Not suspicious: the nodule looks benign, with an estimated cancer risk under 2%. No biopsy needed; it may simply be watched.
  • TR3 — Mildly suspicious: a low estimated risk, broadly around 5%. Most TR3 nodules are benign and are usually followed rather than biopsied straight away.
  • TR4 — Moderately suspicious: a higher estimated risk, broadly 5%–20%. This is the level where a biopsy is often recommended, depending on size.
  • TR5 — Highly suspicious: the highest level, with an estimated risk of around 20% or more. A biopsy is usually advised so the nodule can be sampled and the answer made clear.

Even a TR5 nodule is often benign after biopsy. The score sorts nodules by risk — it does not label any of them as cancer. Have your TI-RADS report reviewed by a CION specialist for free.

A TI-RADS Score Is Not a Cancer Diagnosis

This is the single most important thing to understand about your report. TI-RADS estimates risk from the look of a nodule on ultrasound — it cannot see the actual cells. A nodule can look suspicious and be entirely benign, and occasionally a quiet-looking nodule needs a second glance.

The only way to know for certain whether a nodule is cancer is a fine needle aspiration (FNAC) — a quick, simple test that takes a tiny sample of cells with a very thin needle. TI-RADS does not replace this; it simply helps decide which nodules are worth sampling, so you avoid an unnecessary biopsy of a clearly benign one.

So a higher TI-RADS level is a reason to get a clear answer — not a reason to assume the worst. You can read more about the full pathway on our thyroid cancer diagnosis page.

Confused by Your TI-RADS Score? Talk to a Specialist

Free 45-minute consultation across our Hyderabad locations. Bring your ultrasound report — we will explain exactly what it means.

or
Call 1800 202 8726
12+ Centres in Hyderabad · Pick yours

CION cancer care is closer than you think.

We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.

Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.

Help me pick the right centre
Meet the Specialists

17+ senior cancer specialists. One panel for your case.

Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.

Dr. Naresh Gundu
Medical Oncologist

Dr. Naresh Gundu

MBBS, DNB (Internal Medicine), DM (Medical Oncology)

View Profile
Dr. C. Raghavendra Reddy
Medical Oncologist

Dr. C. Raghavendra Reddy

MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)

View Profile
Dr. Bharati Devi Gorantla
Medical Oncologist

Dr. Bharati Devi Gorantla

MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)

View Profile
Dr. Owais Mohammed
Medical Oncologist

Dr. Owais Mohammed

MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)

View Profile
Dr. T. Raghavender Reddy
Medical Oncologist

Dr. T. Raghavender Reddy

MBBS, DM (Medical Oncology), MD (Radiation Oncology)

View Profile
Dr. N. Kiranmayee
Medical Oncologist

Dr. N. Kiranmayee

MBBS, DM (Medical Oncology), MD (Internal Medicine)

View Profile
Dr. Muralidhar Muddusetty
Surgical Oncologist

Dr. Muralidhar Muddusetty

MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)

View Profile
Dr. Raghavendra Naik
Surgical Oncologist

Dr. Raghavendra Naik

MBBS, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Mohammed  Imaduddin
Surgical Oncologist

Dr. Mohammed Imaduddin

M.B.B.S, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Vinay Mamidala
Surgical Oncologist

Dr. Vinay Mamidala

MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)

View Profile
Dr. Paila Gowri Naidu
Surgical Oncologist

Dr. Paila Gowri Naidu

MBBS, MS (General Surgery), M.Ch (Surgical Oncology), FMAS

View Profile
Dr. Venkata Sushma P
Radiation Oncologist

Dr. Venkata Sushma P

MBBS, MD (Radiation Oncology)

View Profile
Dr. Kirti Ranjan Mohanty
Radiation Oncologist

Dr. Kirti Ranjan Mohanty

MBBS, MD (Radiation Oncology)

View Profile
Dr. Gangadhar Vajrala
Radiation Oncologist

Dr. Gangadhar Vajrala

MBBS, MD (Radiation Oncology), MPH

View Profile
Dr. Basudev Pokhrel
Hematologist

Dr. Basudev Pokhrel

MBBS, M.D (Immunohematology & Blood Transfusion)

View Profile
Dr. Mohammed Imran
Interventional Radiologist

Dr. Mohammed Imran

View Profile
Dr. Vajja Sandeep Kumar
Surgical Oncologist

Dr. Vajja Sandeep Kumar

MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology

View Profile
Dr. Sridhar Kamani
Surgical Oncologist

Dr. Sridhar Kamani

MBBS, MS (General Surgery), DrNB (Surgical Oncology)

View Profile

Want a specific doctor for your case? Mention them when booking.

Book Free Consultation

Your Score Deserves a Clear Explanation

A number on a report should never leave you guessing. We walk this journey with you — explaining the score, arranging a biopsy only if it is genuinely needed, with no rushed decisions and no unnecessary tests.

Get Second Opinion (Free) Call 1800 202 8726
thyroid ultrasound score · cancer risk

How a TI-RADS Score Is Worked Out

The radiologist looks at five features of the nodule on ultrasound. Each feature earns points, and the points are added up. The total decides the TI-RADS level — the more suspicious features a nodule has, the higher its score.

Composition

Whether the nodule is solid, fluid-filled (cystic), or a mix of both. A purely fluid-filled nodule is almost always benign and scores no points, while a fully solid one scores more.

Echogenicity

How dark or bright the nodule appears compared with the rest of the thyroid. A nodule that is markedly darker (very hypoechoic) is more suspicious and scores higher.

Shape

Whether the nodule is "taller-than-wide" — meaning it is deeper than it is broad. This shape is more often linked with cancer, so it adds points.

Margin

Whether the edge of the nodule is smooth, lobulated, irregular, or pushing beyond the thyroid border. A smooth edge is reassuring; an irregular or extending one scores more.

Echogenic foci

Bright spots inside the nodule, such as microcalcifications. Tiny bright punctate spots are one of the more suspicious signs and add the most points.

Did you know?

Under ACR TI-RADS, the five features add up to a total: 0 points is TR1, 2 points is TR2, 3 points is TR3, 4–6 points is TR4, and 7 or more points is TR5. The same nodule, scored by the rules, lands in the same category in any clinic — that consistency is the whole point of the system. (Source: ACR TI-RADS White Paper, JACR.)

When a biopsy is advised

TI-RADS Level, Risk and When a Biopsy Is Needed

Whether a nodule is biopsied depends on both its TI-RADS level and its size. The thresholds below are the ACR TI-RADS recommendations. Smaller nodules below the threshold are usually followed with a repeat ultrasound instead of an immediate biopsy.

Level What it means Estimated cancer risk Biopsy (FNAC) advised when…
TR1 Benign ~0% Not needed
TR2 Not suspicious Under 2% Not needed
TR3 Mildly suspicious ~5% Nodule is 2.5 cm or larger
TR4 Moderately suspicious ~5%–20% Nodule is 1.5 cm or larger
TR5 Highly suspicious ~20% or more Nodule is 1 cm or larger

Risk percentages are broad ACR-based estimates and vary between studies; your specialist interprets them for your specific nodule. Source: American College of Radiology (ACR) TI-RADS. A biopsy decision is never made on the score alone.

Find Out If Your Nodule Needs a Biopsy

Book a free 45-minute consultation with a CION oncologist. We arrange a biopsy only if it is genuinely needed — no unnecessary tests.

or
Call 1800 202 8726

What to Do After You Get a TI-RADS Score

Whatever number is on your report, the next step is the same — a calm, clear review by a thyroid specialist, not panic. Here is how to read your result.

TR1 or TR2. Reassuring. No biopsy is needed. Your doctor may suggest an occasional ultrasound just to confirm the nodule stays stable.

TR3. Low risk. A biopsy is usually advised only if the nodule is 2.5 cm or larger; otherwise it is simply followed with a repeat scan.

TR4 or TR5. Worth sampling. A fine needle aspiration is generally recommended once the nodule reaches the size threshold, so you get a definite answer. This is the most useful time to see a specialist promptly — not because cancer is certain, but because a quick test removes the uncertainty.

If you are unsure what your score means or whether you need a biopsy, our team is glad to read your report with you. Learn more about the tests involved on our thyroid cancer diagnosis page, or explore thyroid cancer treatment if a diagnosis has already been made.

Why Patients Bring Their TI-RADS Report to CION

If you want your score explained properly — without being pushed into unnecessary tests — here is what you can expect at CION Cancer Clinics.

  • Free written second opinion — bring an existing ultrasound report and have it reviewed at no cost
  • Free 45-minute consultation — unhurried time with a specialist to explain your score and what it means for you
  • No unnecessary tests, ever — a biopsy is arranged only when the level and size genuinely call for it
  • Tumour board for every patient — your case is reviewed by a team, not one doctor's opinion
  • 35+ centres across Telangana & AP — scan and review close to home, with less travel
  • Transparent costs and clear next steps — decisions for healing, not billing

A TI-RADS score is not a verdict — it is a starting point. Book a free consultation and let us turn the number into a plan.

From our patients

People Who Got Their Score Explained — and Found Peace of Mind

Real stories from patients who brought an anxious-looking report, got a clear answer, and walked the journey with our team.

Book Free Consultation Call 1800 202 8726
Real Stories. Real Voices.

15,000+ patients chose CION. Hear from them directly.

These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.

4.8★800+ Google reviews
50+video testimonials
15,000+patients treated
Successful Chemotherapy Done by Dr. C Raghavendra Reddy

Successful Chemotherapy Done by Dr. C Raghavendra Reddy

Watch video →
Surgery, Chemo & Radiation Done by  Dr. Imaduddin, Dr. Vinay, Dr. Owais, Dr. Kirti

Surgery, Chemo & Radiation Done by Dr. Imaduddin, Dr. Vinay, Dr. Owais, Dr. Kirti

Watch video →
 Successful Radical Thymectomy Done by  Dr. Mohammed Imaduddin & Dr. Vinay Mamidala

Successful Radical Thymectomy Done by Dr. Mohammed Imaduddin & Dr. Vinay Mamidala

Watch video →
Successful Surgery Done  by Dr. Rajender Byshetty

Successful Surgery Done by Dr. Rajender Byshetty

Watch video →
Successful Chemo & Surgery Done by  Dr. Imad, Dr. Vinay, Dr. Owais & Dr. Raghavendra

Successful Chemo & Surgery Done by Dr. Imad, Dr. Vinay, Dr. Owais & Dr. Raghavendra

Watch video →
Successful Chemo & Surgery Done by  Dr. Imad, Dr. Vinay, Dr. Owais & Dr. Raghavendra

Successful Chemo & Surgery Done by Dr. Imad, Dr. Vinay, Dr. Owais & Dr. Raghavendra

Watch video →
Successful Chemo & Radiation Done by Dr. Owais Mohammed & Dr. Kirti Ranjan Mohanty

Successful Chemo & Radiation Done by Dr. Owais Mohammed & Dr. Kirti Ranjan Mohanty

Watch video →
Successful Breast Cancer Surgery Done by Dr. Imaduddin Mohammed & Dr. Vinay Mamidala

Successful Breast Cancer Surgery Done by Dr. Imaduddin Mohammed & Dr. Vinay Mamidala

Watch video →
Successful Chemotherapy Done by Dr. Bharati Devi Gorantla

Successful Chemotherapy Done by Dr. Bharati Devi Gorantla

Watch video →
Successful Chemo & Surgery Done by Dr. Owais Mohammed & Dr. Imaduddin Mohammed

Successful Chemo & Surgery Done by Dr. Owais Mohammed & Dr. Imaduddin Mohammed

Watch video →
Successful Chemotherapy Done by Dr. Gundu Naresh

Successful Chemotherapy Done by Dr. Gundu Naresh

Watch video →
Successful Bone Marrow Transplantation - Neuroblastoma

Successful Bone Marrow Transplantation - Neuroblastoma

Watch video →
Successful Surgery & Chemo - Carcinoma of Caecum

Successful Surgery & Chemo - Carcinoma of Caecum

Watch video →
Successful Oral chemotherapy & mastectomy surgery

Successful Oral chemotherapy & mastectomy surgery

Watch video →
Successful Oral chemotherapy & mastectomy surgery

Successful Oral chemotherapy & mastectomy surgery

Watch video →
Successful Chemotherapy

Successful Chemotherapy

Watch video →
Successful Surgery by Dr. Mohammed Imaduddin

Successful Surgery by Dr. Mohammed Imaduddin

Watch video →
Successful Bone Marrow Transplantation

Successful Bone Marrow Transplantation

Watch video →
Successful Oral chemotherapy & mastectomy surgery

Successful Oral chemotherapy & mastectomy surgery

Watch video →
Successful Oral chemotherapy & mastectomy surgery

Successful Oral chemotherapy & mastectomy surgery

Watch video →
Successful Chemotherapy

Successful Chemotherapy

Watch video →
Successful Buccal Mucosa Surgery

Successful Buccal Mucosa Surgery

Watch video →
Successful Complex Surgery Mandibulectomy Reconstruction

Successful Complex Surgery Mandibulectomy Reconstruction

Watch video →
Common questions

TI-RADS — Your Questions Answered

What is TI-RADS in a thyroid ultrasound report?
TI-RADS stands for Thyroid Imaging Reporting and Data System. It is a standardised score, published by the American College of Radiology, that a radiologist uses to describe how suspicious a thyroid nodule looks on ultrasound. The nodule is scored on five features — composition, echogenicity, shape, margin and echogenic foci — and the points are added up. The total places the nodule on a scale from TR1 (benign) to TR5 (highly suspicious). The score is an estimate of risk, not a diagnosis — only a biopsy can confirm whether a nodule is cancer.
What does TI-RADS 3 mean?
TI-RADS 3 (TR3) means the nodule is mildly suspicious on ultrasound. The estimated risk of cancer is low — broadly in the region of 5%. Most TR3 nodules turn out to be benign. Under ACR TI-RADS, a biopsy is generally advised only if a TR3 nodule is 2.5 cm or larger; smaller TR3 nodules are usually watched with a follow-up ultrasound rather than biopsied straight away. Your specialist will weigh the score against the nodule's size and your own history before recommending the next step.
What does TI-RADS 4 mean?
TI-RADS 4 (TR4) means the nodule is moderately suspicious. The estimated risk of cancer is higher than TR3 — broadly in the region of 5% to 20%. Because of this, ACR TI-RADS generally recommends a fine needle aspiration biopsy (FNAC) for a TR4 nodule that is 1.5 cm or larger, and a follow-up ultrasound for smaller ones. A TR4 result does not mean you have cancer; it means the nodule has enough suspicious features to be worth sampling so you get a clear answer.
What does TI-RADS 5 mean — is it cancer?
TI-RADS 5 (TR5) means the nodule is highly suspicious on ultrasound, with an estimated cancer risk of around 20% or more. It is the highest TI-RADS level, but it is still not a diagnosis of cancer — many TR5 nodules are biopsied and found to be benign. ACR TI-RADS advises a fine needle aspiration biopsy for a TR5 nodule that is 1 cm or larger. A TR5 score is the clearest signal that you should see a thyroid specialist promptly so the nodule can be sampled and the situation made clear.
What TI-RADS score needs a biopsy?
Whether a biopsy is needed depends on both the TI-RADS level and the size of the nodule. Under ACR TI-RADS, a biopsy (FNAC) is generally advised when a TR3 nodule is 2.5 cm or larger, a TR4 nodule is 1.5 cm or larger, or a TR5 nodule is 1 cm or larger. TR1 and TR2 nodules are considered benign and do not need a biopsy. Smaller nodules that do not meet the size threshold are usually followed with a repeat ultrasound instead. Your specialist makes the final call, taking your history into account.
Are TI-RADS 1 and 2 nodules safe?
TI-RADS 1 (TR1) means no nodule of concern was seen — a normal result. TI-RADS 2 (TR2) means the nodule is not suspicious, or benign, with an estimated cancer risk under 2%. Both are reassuring, and neither needs a biopsy under ACR TI-RADS. A TR2 nodule may still be followed with an occasional ultrasound, mainly to confirm it stays stable in size. As always, the score is a guide — if anything changes, such as the nodule growing or new symptoms appearing, it is worth getting reviewed again.
How is a TI-RADS score calculated?
The radiologist scores the nodule on five ultrasound features and adds the points together. Composition (is it solid, cystic or mixed), echogenicity (how dark or bright it appears), shape (is it taller-than-wide), margin (is the edge smooth or irregular) and echogenic foci (bright spots such as microcalcifications) each contribute points. The total maps to a level: 0 points is TR1, 2 points is TR2, 3 points is TR3, 4 to 6 points is TR4, and 7 or more points is TR5. The more suspicious features a nodule has, the higher its score.
Is a high TI-RADS score the same as a cancer diagnosis?
No. A TI-RADS score is an estimate of how likely a nodule is to be cancer based only on its ultrasound appearance — it is not a diagnosis. Even a TR5 nodule, the most suspicious category, is often found to be benign after biopsy. The only way to confirm whether a nodule is cancer is a fine needle aspiration (FNAC), where a thin needle takes a small sample of cells to examine under a microscope. TI-RADS simply helps decide which nodules are worth sampling, so you avoid unnecessary biopsies of clearly benign ones.
My report says TI-RADS 4 — what should I do next?
A TR4 result means the nodule is moderately suspicious and usually warrants a fine needle aspiration biopsy if it is 1.5 cm or larger. The sensible next step is to see a thyroid specialist who can review the full ultrasound, confirm whether a biopsy is needed, and arrange it if so. At CION Cancer Clinics you can book a free 45-minute consultation, bring your report for a free written second opinion, and have any biopsy arranged only when it is genuinely needed. A clear answer is usually just one quick test away — there is rarely any reason to panic.

Disclaimer: This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. TI-RADS levels, risk estimates and biopsy size thresholds follow the American College of Radiology (ACR) TI-RADS recommendations and may vary with the system in use. Always consult a qualified specialist for guidance specific to your situation. This page is periodically reviewed and updated by CION's medical team in line with current clinical guidelines.

Explore more

Thyroid Cancer Topics

Browse our complete guide to thyroid cancer — types, symptoms, causes, tests, stages and treatment. Tap any topic to read more.

Call now Book free consultation